Related Experiment Video
Updated: Aug 11, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Angiographic frame counts 90 minutes after streptokinase predict left ventricular function at 48 hours following
J K French1, I T Straznicky, B J Webber
1Department of Cardiology, Green Lane Hospital, Private Bag 92189, Auckland 1030, New Zealand. johnf@ahsl.co.nz
Insights
The 90-minute corrected thrombolysis in myocardial infarction frame count (CTFC) predicts heart function after treatment. Higher CTFC values indicate better left ventricular function post-myocardial infarction.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Imaging
Background:
- Myocardial infarction (MI) treatment aims to restore blood flow and preserve left ventricular (LV) function.
- Early assessment of reperfusion and its impact on LV function is crucial for patient outcomes.
Purpose of the Study:
- To determine if the 90-minute corrected thrombolysis in myocardial infarction frame count (CTFC) in the infarct-related artery predicts LV function at 48 hours.
- To evaluate the predictive value of CTFC in patients receiving aspirin, streptokinase, and either heparin or Hirulog.
Main Methods:
- Analysis of 251 patients from the HERO-1 trial with acute MI.
- Coronary angiography performed at 90 minutes to calculate CTFC in the infarct-related artery.
- Left ventriculography at 48 hours to assess LV function (ejection fraction, end-systolic volume, infarct zone score).
Main Results:
- A CTFC ≤ 40 frames at 90 minutes was associated with significantly better LV function at 48 hours.
- This included a lower mean chord score, smaller fraction of chords below normal, smaller end-systolic volume, and higher LV ejection fraction.
- A CTFC ≤ 27 frames also showed trends towards improved LV function.
Conclusions:
- The 90-minute CTFC is a reliable predictor of left ventricular function 48 hours after streptokinase treatment for myocardial infarction.
- The optimal CTFC threshold for predicting better ventricular function may be higher than previously established values from non-infarct populations.
Objective:
To assess whether the 90 minute corrected thrombolysis in myocardial infarction frame count (CTFC) in the infarct related artery predicts left ventricular function at 48 hours in patients with myocardial infarction treated with aspirin, streptokinase, and either heparin or Hirulog.
Design And Setting:
Analysis of 251 patients with acute myocardial infarction enrolled in the international, multicentre Hirulog early reperfusion/occlusion (HERO-1) trial, who underwent both 90 minute coronary angiography and 48 hour left ventriculography.
Main Outcome Variables:
The CTFC was determined in the infarct related artery 90 minutes after starting intravenous streptokinase (1.5 x 106 U over 30 to 60 minutes), and compared with indices of left ventricular function assessed by contrast ventriculography at 48 hours.
Results:
A CTFC of = 27 frames (previously reported mean + 2 SD in coronary arteries of patients without acute infarction) occurred in 29% of infarct related arteries, and was associated with a lower infarct zone mean chord score (-2.06 v -2.54, p = 0.01), a lower fraction of chords > 2 SD below normal (37% v 51%, p = 0.005), and trends towards higher left ventricular ejection fractions (60.9% v 58.2%, p = 0.11) and lower end systolic volumes (50.1 ml v 55.9 ml, p = 0.23). A CTFC of = 40 at 90 minutes occurred in 50% of infarct related arteries, and was associated with a significantly lower mean chord score (-2.20 v -2.60, p = 0.02), a smaller fraction of chords > 2 SD below normal (41% v 52%, p = 0.025), a smaller end systolic volume (49.1 ml v 59.3 ml, p = 0.02), and a higher left ventricular ejection fraction (60.4% v 56.5%, p = 0.03).
Conclusions:
The 90 minute CTFC predicts left ventricular function at 48 hours following streptokinase. The CTFC associated with better ventricular function may be higher than values determined from a non-infarct population.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies

